ID

17182

Description

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00383487

Link

https://clinicaltrials.gov/show/NCT00383487

Keywords

Versions (1)
  1. 8/30/16 8/30/16 -
Uploaded on

August 30, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostatic Neoplasms NCT00383487

English

Eligibility Prostatic Neoplasms NCT00383487

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must give written informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
histologically confirmed adenocarcinoma of the prostate
Description

adenocarcinoma of the prostate

Data type

boolean

Alias
UMLS CUI [1]
C0007112
biochemical relapse after primary radiation therapy or surgery
Description

biochemical relapse

Data type

boolean

Alias
UMLS CUI [1]
C2985506
normal testosterone levels
Description

testosterone level

Data type

boolean

Alias
UMLS CUI [1]
C0523912
3 rising psa after nadir, with interval between psa determinations > 2 weeks
Description

rising psa

Data type

boolean

Alias
UMLS CUI [1]
C0201544
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
local recurrence by ct scan
Description

local recurrence

Data type

boolean

Alias
UMLS CUI [1]
C0027643
distant metastases by bone scan
Description

distant metastasis

Data type

boolean

Alias
UMLS CUI [1]
C1269798
hypercalcemia
Description

hypercalcemia

Data type

boolean

Alias
UMLS CUI [1]
C0020437
nephrolithiasis
Description

nephrolithiasis

Data type

boolean

Alias
UMLS CUI [1]
C0392525
renal insufficiency (serum creatinine > 1.8 mg/dl)
Description

serum creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
pancreatitis
Description

pancreatitis

Data type

boolean

Alias
UMLS CUI [1]
C0030305
history of ulcer or gastrointestinal bleeding
Description

ulcer or gastrointestinal bleeding

Data type

boolean

Alias
UMLS CUI [1]
C0030920
UMLS CUI [2]
C0017181
more than 6 months of hormone ablation therapy
Description

hormone ablation therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279492
concurrent therapy for prostate cancer
Description

concurrent therapy for prostate cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0600139
uncontrolled htn
Description

uncontrolled hypertension

Data type

boolean

Alias
UMLS CUI [1]
C1868885
h/o mi, cva, tia
Description

Myocardial Infarction, Cerebrovascular accident, Transient Ischemic Attack

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
known coronary disease/cerebrovascular disease
Description

coronary disease/cerebrovascular disease

Data type

boolean

Alias
UMLS CUI [1]
C0010068
UMLS CUI [2]
C0007820
platelet counts <50
Description

platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0032181
patients on anticoagulants
Description

anticoagulants

Data type

boolean

Alias
UMLS CUI [1]
C0003280
patients on lithium
Description

Lithium

Data type

boolean

Alias
UMLS CUI [1]
C0023870
Back to the top of the page

Similar models

Eligibility Prostatic Neoplasms NCT00383487

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
must give written informed consent
boolean
C0021430 (UMLS CUI [1])
adenocarcinoma of the prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
biochemical relapse
Item
biochemical relapse after primary radiation therapy or surgery
boolean
C2985506 (UMLS CUI [1])
testosterone level
Item
normal testosterone levels
boolean
C0523912 (UMLS CUI [1])
rising psa
Item
3 rising psa after nadir, with interval between psa determinations > 2 weeks
boolean
C0201544 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
local recurrence
Item
local recurrence by ct scan
boolean
C0027643 (UMLS CUI [1])
distant metastasis
Item
distant metastases by bone scan
boolean
C1269798 (UMLS CUI [1])
hypercalcemia
Item
hypercalcemia
boolean
C0020437 (UMLS CUI [1])
nephrolithiasis
Item
nephrolithiasis
boolean
C0392525 (UMLS CUI [1])
serum creatinine
Item
renal insufficiency (serum creatinine > 1.8 mg/dl)
boolean
C0201976 (UMLS CUI [1])
pancreatitis
Item
pancreatitis
boolean
C0030305 (UMLS CUI [1])
ulcer or gastrointestinal bleeding
Item
history of ulcer or gastrointestinal bleeding
boolean
C0030920 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
hormone ablation therapy
Item
more than 6 months of hormone ablation therapy
boolean
C0279492 (UMLS CUI [1])
concurrent therapy for prostate cancer
Item
concurrent therapy for prostate cancer
boolean
C0009429 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
uncontrolled hypertension
Item
uncontrolled htn
boolean
C1868885 (UMLS CUI [1])
Myocardial Infarction, Cerebrovascular accident, Transient Ischemic Attack
Item
h/o mi, cva, tia
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
coronary disease/cerebrovascular disease
Item
known coronary disease/cerebrovascular disease
boolean
C0010068 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
platelet count
Item
platelet counts <50
boolean
C0032181 (UMLS CUI [1])
anticoagulants
Item
patients on anticoagulants
boolean
C0003280 (UMLS CUI [1])
Lithium
Item
patients on lithium
boolean
C0023870 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial